A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers
Clinical trial NCT01733108 · COMPLETED
Trial details
- NCT number
- NCT01733108
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2008-09-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.